跳至主要内容
临床试验/NL-OMON53042
NL-OMON53042招募中不适用

Immunogenicity of HPV-vaccination in a reduced-dose schedule - HPV-2/1D

RIVM0 个研究点目标入组 1,305 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,305

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 64(—)

入选标准

  • In order to be eligible to participate in the cohort study among girls, a
  • subject must meet all of the following criteria:
  • - Vaccinated with the bivalent HPV vaccine (Cervarix)
  • - Received one-, two- (with at least five months interval) or three-doses
  • (0,1,6 months) of the
  • - Born between 1997 and 2003
  • The inclusion criteria for the cohort study among boys are as follows:
  • - Vaccinated with the bivalent HPV vaccine (Cervarix)
  • - Received two-doses (with at least five months interval) of the vaccine
  • - Born in 2012

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • - unknown or incorrect address
  • - participated in tolerability study and stated to no longer be approachable
  • for further research

研究者

发起方
RIVM

相似试验